Liminatus Pharma, Inc. (LIMN) stock chart

LIMNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as LIMNW

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30

$2.77−0.17 (-5.78%)

Close on Nov 12, 2026Market cap $186.03MP/E –Yield –

Daily, weekly, monthly, quarterly and yearly candles from end-of-day prices, adjusted for splits. Marks along the bottom: E for earnings, D for ex-dividend dates, S for stock splits. Drawings are saved in this browser for each symbol; indicators and chart settings carry across symbols.

See a number that looks wrong?